GRITSTONE BIO INC (GRTS) Stock Balance Sheet
NASDAQ:GRTS - Nasdaq - US39868T1051 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 17.01M | 17.30M | 12.00M | 133.30M | |||
| Cash Equivalents | 50.90M | 45.98M | 38.20M | 81.30M | 36.80M | |||
| Marketable Securities | 4.81M | 16.29M | 116.40M | 108.30M | 1.00M | |||
| Receivables | 195.00K | 231.00K | 700.00K | 1.40M | N/A | |||
| Other Current Assets | 4.80M | 7.93M | 10.40M | 17.60M | 4.30M | |||
| Total Current Assets | 60.71M | 87.44M | 182.90M | 220.60M | 175.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 76.53M | 84.12M | 38.80M | 44.50M | 43.40M | |||
| Investments And Advances | N/A | 0.00 | 4.00M | 4.60M | N/A | |||
| Other Non-Current Assets | 5.30M | 6.21M | 15.00M | 8.40M | 2.70M | |||
| Total Non-Current Assets | 81.83M | 90.33M | 57.90M | 57.50M | 46.20M | |||
| TOTAL ASSETS | 142.54M | 177.77M | 240.80M | 278.10M | 221.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.29M | 21.17M | 21.00M | 18.50M | 13.90M | |||
| Accounts Payable | 4.13M | 3.82M | 8.70M | 4.20M | 9.60M | |||
| Other Current Liabilities | 3.48M | 2.35M | 5.10M | 17.20M | 3.50M | |||
| Total Current Liabilities | 23.90M | 27.34M | 34.80M | 40.00M | 27.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 40.51M | 40.14M | 19.30M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 55.95M | 58.44M | 15.80M | 22.10M | 27.80M | |||
| Total Non-Current Liabilities | 96.45M | 98.58M | 35.20M | 22.00M | 27.80M | |||
| TOTAL LIABILITIES | 120.35M | 125.92M | 70.00M | 62.00M | 54.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -723.34M | -659.56M | -521.10M | -401.40M | -326.30M | |||
| Additional Paid In Capital | 745.51M | 711.39M | 691.90M | 617.50M | 493.00M | |||
| Common Shares | 24.00K | 22.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -3.00K | 3.00K | -100.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 117.79M | 97.59M | 86.90M | 68.00M | 47.60M | |||
| Tangible Book Value per Share | 0.19 | 0.53 | 1.97 | 3.18 | 3.50 | |||
| Total Shareholders' Equity | 22.19M | 51.85M | 170.80M | 216.10M | 166.70M | |||
| TOTAL LIABILITIES AND EQUITY | 142.54M | 177.77M | 240.80M | 278.10M | 221.60M | |||
| Statistics | ||||||||
| Debt/Equity | 1.83 | 0.77 | 0.11 | N/A | N/A | |||
| Current Ratio | 2.54 | 3.20 | 5.26 | 5.51 | 6.50 | |||
| Return On Assets (ROA) | -93.33% | -77.90% | -49.71% | -27.00% | -47.52% | |||
| Return On Equity (ROE) | -599.53% | -267.10% | -70.08% | -34.74% | -63.17% | |||
All data in USD , ROIC based on taxRate of 0.21